ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors

May 27, 2026 updated by: Jamie Faro, University of Massachusetts, Worcester

ActivityChoice: A Clinic-delivered Implementation Program to Increase Physical Activity and Decrease Cardiovascular Disease Risk Amongst Cancer Survivors

Cardiovascular disease, the number one leading cause of death in the United States, is highly prevalent in cancer survivors. Physical activity can reduce risk, and referrals to programs addressing survivors' choices are highly recommended from providers in cancer survivorship, though rarely implemented. The study team proposes to develop ActivityChoice, a clinic-based implementation program, using patient narrative decision aids to support choices to a group in-person, group virtual, or self-monitored digital health physical activity program.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

114

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Worcester, Massachusetts, United States, 01605
        • University of Massachusetts Chan Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

AIM 1 Inclusion Criteria for Aim 1a

  1. Prior cancer diagnosis
  2. 18 years of age and older
  3. Speaks English

Exclusion Criteria for Aim 1a

  1. No prior cancer diagnosis
  2. Under 18 years of age
  3. Prisoners
  4. Does not speak English

AIM1B Survivor Inclusion Criteria for Aim 1b

  1. Prior cancer diagnosis
  2. 18 years of age and older
  3. Speaks English

Survivor Exclusion Criteria for 1b

  1. No prior cancer diagnosis
  2. Under 18 years of age
  3. Does not speak English
  4. Prisoners
  5. Participated in Aim 1a

Clinic Staff Inclusion Criteria for Aim 1b

  1. Provide cancer care for patients at one of the four UMass cancer clinics,
  2. Involved in survivorship care planning visits
  3. Speaks English
  4. 18 years of age and older

Clinic Staff Exclusion Criteria for 1b

  1. Is not employed at one of the four UMass cancer clinics
  2. Is not involved in survivorship care planning visits
  3. Does not speak English
  4. Prisoners
  5. Under 18 years of age

Pregnant Women Pregnant women may be included in this study as an incidental population.

AIM 2 Clinic Staff Inclusion Criteria for Aim 2

  1. Provide cancer care for patients at one of the four UMass cancer clinics
  2. Involved in survivorship care visits
  3. Speaks English
  4. 18 years of age and older

Clinic Staff Exclusion Criteria for Aim 2

  1. Is not employed at one of the four UMass cancer clinics
  2. Is not involved in survivorship care visits
  3. Does not speak English
  4. Prisoners
  5. Under 18 years of age

Survivor Inclusion Criteria for Aim 2

  1. Cancer Patient at one of the four UMass cancer clinics
  2. Has a survivorship care planning visit
  3. Able to perform physical activity
  4. Completes Physical Activity Readiness Questionnaire (PAR-Q) physical activity readiness questionnaire or has medical clearance to participate
  5. Has a smartphone
  6. Speaks English
  7. 18 years of age and older

Survivor Exclusion Criteria for Aim 2:

  1. Not a cancer patient at one of the four UMass cancer clinics
  2. Does not have a survivorship care planning visit
  3. Unable to perform physical activity or no medical clearance to participate
  4. Does not speak English
  5. Under 18 years of age
  6. Does not have a smartphone
  7. Prisoners
  8. Is pregnant

AIM 3 Clinic Staff Inclusion Criteria for Aim 3

  1. Are enrolled in ActivityChoice
  2. ≥ 18 years of age
  3. Provide written informed consent

Patient Inclusion Criteria for Aim 3

  1. Are enrolled in ActivityChoice
  2. Had a clinic visit with one of the enrolled clinic staff during the study period
  3. ≥ 18 years of age
  4. Speaks English
  5. Provide written informed consent

Patient Exclusion Criteria for Aim 3

  1. Not enrolled in ActivityChoice
  2. Was not seen in the clinic by an enrolled clinic staff during the study period

UMass Cancer Clinic Administration Inclusion Criteria for Aim 3

  1. Are ≥ 18 years of age
  2. Are in positions of cancer center leadership
  3. Provide written informed consent

UMass Cancer Clinic Administration Exclusion Criteria for Aim 3

  1. Unable or unwilling to provide written informed consent
  2. Not in positions of leadership within the UMass Medical Cancer Clinic Administration
  3. <18 years of age.

External site stakeholders Inclusion Criteria for Aim 3

  1. Are ≥18 years of age
  2. Are in positions of cancer center leadership
  3. Provide written informed consent.

External site stakeholders Exclusion Criteria for Aim 3

  1. Unable or unwilling to provide written informed consent
  2. Not in positions of leadership overseeing cancer survivorship
  3. <18 years of age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Referral
Provider education/training on referral process Patient education material on physical activity benefits Paper referral to LIVESTRONG at the YMCA Fitbit Activity Monitor
The standard referral period will serve as the "usual care" comparator. Patients will receive a paper referral and Fitbit monitor.
Experimental: Enhanced Referral
Provider education/training on referral process Patient education material on physical activity benefits Patient decision aid on physical activity program choices Electronic referral to program of patient's choice Fitbit Activity Monitor
The enhanced referral uses an electronic referral and patient decision aid to provide choices to 3 different physical activity programs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients referred as obtained by the electronic referral system and electronic health record
Time Frame: Baseline
The number of patients referred/The number of eligible patients
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of eligible clinicians enrolling in the the study
Time Frame: Baseline
Number of enrolled clinicians/Number of eligible clinicians
Baseline
Clinic/Clinician fidelity of delivering patient decision aids
Time Frame: Baseline
Clinic delivery of patient decision aids as reported by patients
Baseline
Patient Engagement
Time Frame: Examined at baseline, 3-, and 6-months
Program enrollment (number referred/number enrolled);
Examined at baseline, 3-, and 6-months
Patient Retention
Time Frame: 3- and 6-months
Percent of enrolled patients completing follow-up surveys at 3- and 6-months
3- and 6-months
Patient narrative decision aid acceptability and effectiveness (Enhanced Referral only)
Time Frame: Baseline following referrals
Acceptability of decision aid using the Ottawa Decision Aid Centre 10-item acceptability of decision aids (Minimum score=0, Maximum score=100; Higher score indicates higher decisional conflict and uncertainty
Baseline following referrals
Patient Autonomous Regulation
Time Frame: Baseline, 3- and 6-months
Behavioral Regulation for Exercise Questionnaire-2 (Minimum=0, Maximum=76; Higher scores indicates greater regulation/motivation)
Baseline, 3- and 6-months
Patient Objective Physical Activity
Time Frame: Baseline, 3- and 6-months
Change from baseline to 3- and 6-months in steps, light, moderate and vigorous physical activity measured via Fitbits.
Baseline, 3- and 6-months
Patient Self-Report Physical Activity
Time Frame: Baseline, 3- and 6-months
Change from baseline to 3- and 6-months in light, moderate and vigorous physical activity survey-measured (Godin leisure time questionnaire) physical activity. The questionnaire is a 4-item self-administered questionnaire with the first three questions seeking information on the number of times one engages in mild, moderate and strenuous leisure-time physical activity bouts of at least 15 min duration in a typical week. Scores can range from 0 to 98, with the higher score meaning a greater level of activity for that week.
Baseline, 3- and 6-months
Patient Health-related Quality of Life
Time Frame: Baseline, 3- and 6-months
Functional Assessment of Cancer Therapy-General (FACT-G): Physical, social, emotional and functional well-being (Minimum=0, Maximum=127; Higher score means a higher quality of life)
Baseline, 3- and 6-months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinician, Patient, Leadership, and External Partner Acceptability
Time Frame: At study completion, within 3 months of enrollment
Semi-structured interviews using interview guides with enrolled clinicians, referred survivors, clinic leadership, and external partners
At study completion, within 3 months of enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jamie M Faro, PhD, UMass Chan Medical School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 11, 2023

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

May 1, 2023

First Submitted That Met QC Criteria

May 22, 2023

First Posted (Actual)

May 23, 2023

Study Record Updates

Last Update Posted (Actual)

June 1, 2026

Last Update Submitted That Met QC Criteria

May 27, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00000522
  • 1K01HL163254 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Standard Referral

Subscribe